Thromboelastography Market, by Type (Standard, RapidTEG, Functional Fibrinogen, Platelet Mapping, and Heparinase), by Application (Cardio-pulmonary Bypass Surgery, Liver Transplantation, Trauma, Obstetrics, and Neonatology and Pediatrics, and Others), by

Thromboelastography Market, by Type (Standard, RapidTEG, Functional Fibrinogen, Platelet Mapping, and Heparinase), by Application (Cardio-pulmonary Bypass Surgery, Liver Transplantation, Trauma, Obstetrics, and Neonatology and Pediatrics, and Others), by End User (Hospitals & Clinics, Blood Banks, Academic Institutes, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Thromboelastography (TEG) is used to measure the visco-elastic properties of blood clot formation. It is a major application in surgery and anesthesiology. Increasing use of TEG machines for blood management has helped in predicting and managing bleeding disorders. It also helps in evaluating the risk for re-operation, which leads to cost saving, as it reduces unnecessary blood component transfusions. This machine has applications in hospitals, blood banks, pharmaceutical, and academic institutes.
Market Dynamics
Rising incidence of surgeries and organ transplant procedures is a major factor that is expected to boost the thromboelastography market growth over the forecast period. For instance, according to U.S. Department of Health and Human Services, 34,770 organ transplants were performed in the U.S in 2017. Rising launch of novel platelet mapping assays and other products is expected to drive the market growth. For instance, in November 2021, Haemonetics Corporation launched the four-channel TEG 6s PlateletMapping ADP & AA assay cartridge. The product is designed for use with TEG 6s Hemostasis Analyzer System.
Key features of the study:
This report provides in-depth analysis of the global thromboelastography market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global thromboelastography market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Haemonetics Corporation, Instrumentation Laboratory, Framar Hemologix srl, Medirox AB, Diagnostica Stago, and Life Diagnostica
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future drug launches, drug class up-gradation, market expansion, and marketing tactics
The global thromboelastography market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global thromboelastography market
Detailed Segmentation:
Global Thromboelastography Market, By Type:
Standard
RapidTEG
Functional Fibrinogen
Platelet Mapping
Heparinase
Consumables & Disposables
Global Thromboelastography Market, By Application:
Cardio-pulmonary Bypass Surgery
Liver Transplantation
Trauma
Obstetrics
Neonatology and Pediatrics
Others
Global Thromboelastography Market, By End User:
Hospitals & Clinics
Blood Banks
Academic Institutes
Others
Global Thromboelastography Market, By Region:
North America
By Type:
Standard
RapidTEG
Functional Fibrinogen
Platelet Mapping
Heparinase
Consumables & Disposables
By Application
Cardio-pulmonary Bypass Surgery
Liver Transplantation
Trauma
Obstetrics
Neonatology and Pediatrics
Others
By End User:
Hospitals & Clinics
Blood Banks
Academic Institutes
Others
By Country:
U.S.
Canada
Latin America
By Type:
Standard
RapidTEG
Functional Fibrinogen
Platelet Mapping
Heparinase
Consumables & Disposables
By Application
Cardio-pulmonary Bypass Surgery
Liver Transplantation
Trauma
Obstetrics
Neonatology and Pediatrics
Others
By End User:
Hospitals & Clinics
Blood Banks
Academic Institutes
Others
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Type:
Standard
RapidTEG
Functional Fibrinogen
Platelet Mapping
Heparinase
Consumables & Disposables
By Application
Cardio-pulmonary Bypass Surgery
Liver Transplantation
Trauma
Obstetrics
Neonatology and Pediatrics
Others
By End User:
Hospitals & Clinics
Blood Banks
Academic Institutes
Others
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Type:
Standard
RapidTEG
Functional Fibrinogen
Platelet Mapping
Heparinase
Consumables & Disposables
By Application
Cardio-pulmonary Bypass Surgery
Liver Transplantation
Trauma
Obstetrics
Neonatology and Pediatrics
Others
By End User:
Hospitals & Clinics
Blood Banks
Academic Institutes
Others
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Type:
Standard
RapidTEG
Functional Fibrinogen
Platelet Mapping
Heparinase
Consumables & Disposables
By Application
Cardio-pulmonary Bypass Surgery
Liver Transplantation
Trauma
Obstetrics
Neonatology and Pediatrics
Others
By End User:
Hospitals & Clinics
Blood Banks
Academic Institutes
Others
By Country:
GCC
Israel
Rest of Middle East
Africa
By Type:
Standard
RapidTEG
Functional Fibrinogen
Platelet Mapping
Heparinase
Consumables & Disposables
By Application
Cardio-pulmonary Bypass Surgery
Liver Transplantation
Trauma
Obstetrics
Neonatology and Pediatrics
Others
By End User:
Hospitals & Clinics
Blood Banks
Academic Institutes
Others
By Country/Region:
South Africa
Central Africa
North Africa
Company Profiles
Haemonetics Corporation*
Company Overview
Product Portfolio
Financial Performance
Key Highlights
Market Strategies
Instrumentation Laboratory
Framar Hemologix srl
Medirox AB
Diagnostica Stago
Life Diagnostica
“*” marked represents similar segmentation in other categories in the respective section.